Aberrant RNA homeostasis in amyotrophic lateral sclerosis

potential for new therapeutic targets?

Christopher J. Donnelly, Jonathan C. Grima, Rita Sattler

Research output: Contribution to journalArticle

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron degeneration. The disease pathogenesis is multifaceted in that multiple cellular and molecular pathways have been identified as contributors to the disease progression. Consequently, numerous therapeutic targets have been pursued for clinical development, unfortunately with little success. The recent discovery of mutations in RNA modulating genes such as TARDBP/TDP-43, FUS/TLS or C9ORF72 changed our understanding of neurodegenerative mechanisms in ALS and introduced the role of dysfunctional RNA processing as a significant contributor to disease pathogenesis. This article discusses the latest findings on such RNA toxicity pathways in ALS and potential novel therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)417-437
Number of pages21
JournalNeurodegenerative disease management
Volume4
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Amyotrophic Lateral Sclerosis
Homeostasis
RNA
Nerve Degeneration
Motor Neurons
Neurodegenerative Diseases
Disease Progression
Therapeutics
Mutation
Genes

Keywords

  • ALS
  • ALS therapeutics
  • C9ORF72
  • repeat expansion
  • RNA toxicity
  • TDP-43

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aberrant RNA homeostasis in amyotrophic lateral sclerosis : potential for new therapeutic targets? / Donnelly, Christopher J.; Grima, Jonathan C.; Sattler, Rita.

In: Neurodegenerative disease management, Vol. 4, No. 6, 2014, p. 417-437.

Research output: Contribution to journalArticle

Donnelly, Christopher J. ; Grima, Jonathan C. ; Sattler, Rita. / Aberrant RNA homeostasis in amyotrophic lateral sclerosis : potential for new therapeutic targets?. In: Neurodegenerative disease management. 2014 ; Vol. 4, No. 6. pp. 417-437.
@article{2a980aff2674492fb3fe08c96d1aa270,
title = "Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?",
abstract = "Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron degeneration. The disease pathogenesis is multifaceted in that multiple cellular and molecular pathways have been identified as contributors to the disease progression. Consequently, numerous therapeutic targets have been pursued for clinical development, unfortunately with little success. The recent discovery of mutations in RNA modulating genes such as TARDBP/TDP-43, FUS/TLS or C9ORF72 changed our understanding of neurodegenerative mechanisms in ALS and introduced the role of dysfunctional RNA processing as a significant contributor to disease pathogenesis. This article discusses the latest findings on such RNA toxicity pathways in ALS and potential novel therapeutic approaches.",
keywords = "ALS, ALS therapeutics, C9ORF72, repeat expansion, RNA toxicity, TDP-43",
author = "Donnelly, {Christopher J.} and Grima, {Jonathan C.} and Rita Sattler",
year = "2014",
doi = "10.2217/nmt.14.36",
language = "English (US)",
volume = "4",
pages = "417--437",
journal = "Neurodegenerative disease management",
issn = "1758-2024",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Aberrant RNA homeostasis in amyotrophic lateral sclerosis

T2 - potential for new therapeutic targets?

AU - Donnelly, Christopher J.

AU - Grima, Jonathan C.

AU - Sattler, Rita

PY - 2014

Y1 - 2014

N2 - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron degeneration. The disease pathogenesis is multifaceted in that multiple cellular and molecular pathways have been identified as contributors to the disease progression. Consequently, numerous therapeutic targets have been pursued for clinical development, unfortunately with little success. The recent discovery of mutations in RNA modulating genes such as TARDBP/TDP-43, FUS/TLS or C9ORF72 changed our understanding of neurodegenerative mechanisms in ALS and introduced the role of dysfunctional RNA processing as a significant contributor to disease pathogenesis. This article discusses the latest findings on such RNA toxicity pathways in ALS and potential novel therapeutic approaches.

AB - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron degeneration. The disease pathogenesis is multifaceted in that multiple cellular and molecular pathways have been identified as contributors to the disease progression. Consequently, numerous therapeutic targets have been pursued for clinical development, unfortunately with little success. The recent discovery of mutations in RNA modulating genes such as TARDBP/TDP-43, FUS/TLS or C9ORF72 changed our understanding of neurodegenerative mechanisms in ALS and introduced the role of dysfunctional RNA processing as a significant contributor to disease pathogenesis. This article discusses the latest findings on such RNA toxicity pathways in ALS and potential novel therapeutic approaches.

KW - ALS

KW - ALS therapeutics

KW - C9ORF72

KW - repeat expansion

KW - RNA toxicity

KW - TDP-43

UR - http://www.scopus.com/inward/record.url?scp=84964312989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964312989&partnerID=8YFLogxK

U2 - 10.2217/nmt.14.36

DO - 10.2217/nmt.14.36

M3 - Article

VL - 4

SP - 417

EP - 437

JO - Neurodegenerative disease management

JF - Neurodegenerative disease management

SN - 1758-2024

IS - 6

ER -